Market Tracker

01/20 5:16pm ET

Sangamo Therapeutics Inc (NASDAQ:SGMO)

3.65
Delayed Data
As of Jan 20
 -0.30 / -7.59%
Today’s Change
2.65
Today|||52-Week Range
7.60
+19.67%
Year-to-Date

Today’s Trading

Previous close3.95
Today’s open3.95
Day’s range3.65 - 4.00
Volume1,230,887
Average volume (3 months)967,142
Market cap$257.8M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-48.72%
Earnings growth (this year)-96.00%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-13.80%
P/E ratioNM
Price/Sales16.11
Price/Book1.33

Competitors

 Today’s
change
Today’s
% change
SYRSSyros Pharmaceutical...-0.10-0.90%
SELBSelecta Biosciences ...-0.07-0.47%
CGENCompugen Ltd-0.05-1.08%
KDMNKadmon Holdings Inc+0.10+2.06%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$39.5M
Annual profit (last year)-$40.7M
Net profit margin-102.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Executive Vice President
Henry Ward Wolff
Corporate headquarters
Richmond, California

Forecasts